Last 5.98 INR
Change Today +0.28 / 4.91%
Volume 1.5K
BRPH On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 07/28/14 All times are local (Market data is delayed by at least 15 minutes).

brawn biotech ltd (BRPH) Snapshot

Open
5.98
Previous Close
5.70
Day High
5.98
Day Low
5.98
52 Week High
09/20/13 - 7.90
52 Week Low
07/29/13 - 3.78
Market Cap
17.9M
Average Volume 10 Days
707.5
EPS TTM
1.17
Shares Outstanding
3.0M
EX-Date
--
P/E TM
5.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for BRAWN BIOTECH LTD (BRPH)

Related News

No related news articles were found.

brawn biotech ltd (BRPH) Related Businessweek News

No Related Businessweek News Found

brawn biotech ltd (BRPH) Details

Brawn Biotech Limited operates as a healthcare group in India and internationally. The company involves in manufacturing, contract manufacturing, and supplying pharmaceutical and healthcare products. It provides various pharmaceutical products, including antibacterial, cardiovascular, anti diabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. Brawn Biotech Limited was founded in 1985 and is based in New Delhi, India.

Founded in 1985

brawn biotech ltd (BRPH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

brawn biotech ltd (BRPH) Key Developments

Brawn Biotech Limited, Board Meeting, May 30, 2014

Brawn Biotech Limited, Board Meeting, May 30, 2014. Agenda: To consider audited results.

Brawn Biotech Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2013

Brawn Biotech Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company reported profit from operations before other income, finance cost and exceptional items of INR 1.482 million, net loss of INR 2.227 million or INR 0.74 per share on net sales/income from operations (net of excise duty) of INR 88.424 million compared to profit from operations before other income, finance cost and exceptional items of INR 1.220 million, net profit of INR 0.847 million or INR 0.03 per share on net sales/income from operations (net of excise duty) of INR 74.793 million for the same period last year. Loss from ordinary activities before tax was INR 2.756 million compared to profit from ordinary activities before tax of INR 1.207 million a year ago. For the nine months, the company reported profit from operations before other income, finance cost and exceptional items of INR 9.231 million, net profit of INR 3.340 million or INR 0.11 per share on net sales/income from operations (net of excise duty) of INR 272.534 million compared to profit from operations before other income, finance cost and exceptional items of INR 4.846 million, net profit of INR 3.335 million or INR 0.11 per share on net sales of INR 177.982 million for the same period last year. Profit from ordinary activities before tax was INR 4.833 million compared to INR 4.802 million a year ago.

Brawn Biotech Limited, Board Meeting, Feb 14, 2014

Brawn Biotech Limited, Board Meeting, Feb 14, 2014. Agenda: To consider the unaudited standalone earnings results for the third quarter and nine months ended December 31, 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRPH:IN 5.98 INR +0.28

BRPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BRPH.
View Industry Companies
 

Industry Analysis

BRPH

Industry Average

Valuation BRPH Industry Range
Price/Earnings 14.6x
Price/Sales 0.0x
Price/Book 0.4x
Price/Cash Flow 12.5x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRAWN BIOTECH LTD, please visit www.brawnpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.